IP Library Granted Patent US 7,004,975
Granted Patent B2
US 7,004,975 · App. 10/983,220 · Granted Feb 28, 2006

Coated joint endoprosthesis

Assignee: ESKA Implants GmbH & Co.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,004,975
App. No.
10/983,220
Granted
Feb 28, 2006
Kind
B2
Abstract

Joint endoprostheses are provides which respectively have a joint part with a metallic core, wherein the metallic core is coated, in regions that roll and/or slide on another joint part during execution of the joint function, with a glass-ceramic composite mixture. In one embodiment, the glass-ceramic has the following composition with approximate amounts in wt. %: Component Amount (wt %) SiO 2 45–50% Al 2 O 3 15–20% ZrO 2  8–12% K 2 O 0–8% Na 2 O   0–7.5% CaO   0–2.5% TiO 2   0–1.5% and furthermore a residual amount of up to about 12.5% of MnO 2 and/or Fe 2 O 3 and/or Co 2 O 3 .

Claims (68)

1. A joint endoprosthesis, comprising a first joint part having a metallic core, wherein the metallic core is coated, in regions that roll and/or slide on a second joint part during execution of a joint function, with a glass-ceramic composite mixture having the following composition in approximate amounts indicated (in wt. %):

Component

Amount (wt %)

SiO 2

45–50%

Al 2 O 3

15–20%

ZrO 2

 8–12%

K 2 O

0–8%

Na 2 O

  0–7.5%

CaO

  0–2.5%

TiO 2

  0–1.5%

and furthermore a residual amount of up to about 12.5% of an oxide selected from the group consisting of MnO 2 , Fe 2 O 3 , Co 2 O 3 and mixture thereof.

2. A joint endoprosthesis, comprising a first joint part having a metallic core, wherein the metallic core is coated, in regions that roll and/or slide on a second joint part during execution of a joint function, with a glass-ceramic composite mixture having the following composition in approximate amounts indicated (in wt. %):

Component

Amount (wt %)

SiO 2

35–55%

Al 2 O 3

15–25%

TiO 2

10–14%

Na 2 O

  0–7.5%

K 2 O

0–7%

ZrO 2

1–5%

CaO

  0–0.5%

and furthermore a residual amount of up to about 24% of and oxide selected from the group consisting of MnO 2 , Fe 2 O 3 , Co 2 O 3 , CuO, and mixtures thereof.

3. A joint endoprosthesis, comprising a first joint part having a metallic core, wherein the metallic core is coated, in regions that roll and/or slide on a second joint part during execution of a joint function, with a glass-ceramic composite mixture having the following composition in approximate amounts indicated (in wt. %):

Component

Amount (wt %)

SiO 2

50–60%

Al 2 O 3

 5–10%

ZrO 2

 5–10%

Na 2 O

0–8%

CaO

0–6%

TiO 2

3–5%

K 2 O

0–2%

Sb 2 O 3

  0–0.5%

and furthermore a residual amount of up to about 20.5% of and oxide selected from the group consisting of MnO 2 , Fe 2 O 3 , Co 2 O 3 , CuO, CeO 2 , and mixtures thereof.

4. The joint endoprosthesis according to claim 1 , wherein the coating has a thickness of about 200 to 600 μm.

5. The joint endoprosthesis according to claim 2 , wherein the coating has a thickness of about 200 to 600 μm.

6. The joint endoprosthesis according to claim 3 , wherein the coating has a thickness of about 200 to 600 μm.

7. The joint endoprosthesis according to claim 1 , wherein the second joint part also has a metallic core which is coated with a glass-ceramic composite mixture of the same composition as the first joint part.

8. The joint endoprosthesis according to claim 2 , wherein the second joint part also has a metallic core which is coated with a glass-ceramic composite mixture of the same composition as the first joint part.

9. The joint endoprosthesis according to claim 3 , wherein the second joint part has a sliding partner comprising a ceramic.

10. The joint endoprosthesis according to claim 3 , wherein the second joint part has a sliding partner comprising polyethylene.

11. The joint endoprosthesis according to claim 1 , wherein the metallic core comprises a cobalt-chromium-molybdenum alloy.

12. The joint endoprosthesis according to claim 2 , wherein the metallic core comprises a cobalt-chromium-molybdenum alloy.

13. The joint endoprosthesis according to claim 3 , wherein the metallic core comprises a cobalt-chromium-molybdenum alloy.

14. The joint endoprosthesis according to claim 7 , wherein the metallic core of the second joint part comprises a cobalt-chromium-molybdenum alloy.

15. The joint endoprosthesis according to claim 8 , wherein the metallic core of the second joint part comprises a cobalt-chromium-molybdenum alloy.

Assignments (5)
CHANGE OF NAME Recorded Mar 29, 2012
From: ESKA IMPLANTS GMBH & CO.
To: ESKA IMPLANTS GMBH & CO. KG
Reel/Frame 027954/0642 →
CHANGE OF NAME Recorded Mar 28, 2012
From: ESKA ORTHODYNAMICS GMBH
To: ORTHODYNAMICS GMBH
Reel/Frame 027950/0344 →
PURCHASE AGREEMENT Recorded Mar 28, 2012
From: ESKA IMPLANTS AG
To: ESKA ORTHODYNAMICS GMBH
Reel/Frame 027950/0441 →
CHANGE OF NAME Recorded Mar 28, 2012
From: ESKA IMPLANTS GMBH & CO. KG
To: ESKA IMPLANTS AG
Reel/Frame 027950/0588 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 27, 2004
From: GRUNDEI, HANS
To: ESKA IMPLANTS GMBH & CO.
Reel/Frame 016098/0063 →
Priority Claims (1)
EP 03025541 · Nov 7, 2003 · regional
Continuity (1)
Related Publication 20050102035A1 · May 12, 2005